Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations. [PDF]
Sakuma M +9 more
europepmc +1 more source
UBA6 specificity for ubiquitin E2 conjugating enzymes reveals a priority mechanism of BIRC6. [PDF]
Riechmann C +5 more
europepmc +1 more source
Lycorine hydrochloride directly targets UBA1 to suppress cellular senescence
Jiaqing Yang +6 more
openaire +3 more sources
The ubiquitin-activating enzyme, UBA1, as a novel therapeutic target for AML
Barghout, Samir H., Schimmer, Aaron D.
openaire +2 more sources
Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-Score. [PDF]
von Bornemann Fløe L +13 more
europepmc +1 more source
VEXAS syndrome: cutaneous manifestations and UBA1 gene variants in the diagnosis of a rare autoinflammatory syndrome - Case report. [PDF]
Crivelatti I +5 more
europepmc +1 more source
Case Report: Diagnostic challenges in VEXAS syndrome with novel ultrastructural lung findings: IgG4-RD and vasculitis as relevant differential diagnoses. [PDF]
Etzel P +3 more
europepmc +1 more source
Primary CD34<sup>+</sup> cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243. [PDF]
Nowak D +21 more
europepmc +1 more source
UBA1-depleted neutrophils disrupt immune homeostasis and induce VEXAS-like autoinflammatory disease in mice. [PDF]
Dong G +15 more
europepmc +1 more source
SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms. [PDF]
Thier J +16 more
europepmc +1 more source

